NCT06479356
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,312 public trials
521 recruiting studies
Recurrence trial results
NCT03658785
- Conditions
- Disease Attributes, Metastatic Cancer, Neoplasm Metastasis, +7 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Recruiting
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
NCT06532058
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
- The First People's Hospital of Changzhou Changzhou, Jiangsu, China
- Huai 'an First People's Hospital Huaian, Jiangsu, China
Recruiting
A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood
NCT06524245
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
- Locations
-
- Peking University Shougang Hospital Beijing, Beijing Municipality, China
NCT06287398
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
- Locations
-
- Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia
NCT05504772
- Conditions
- Childhood Brain Tumor, Childhood Cancer, Childhood Leukemia, +8 more
- Locations
-
- Women's and Children's Hospital Adelaide, Australia
- Queensland Children's Hospital Brisbane, Australia
- Royal Hobart Hospital Hobart, Australia
- Monash Children's Hospital Melbourne, Australia
Recruiting
On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma
NCT06503211
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- PersonGen.Anke Cellular Therapeutice Co., Ltd. Hefei, Anhui, China
NCT06503094
- Conditions
- B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Recruiting
PREventing Second Cancers With DOSTARlimab
NCT05855811
- Conditions
- Disease Attributes, Neoplasms, Neoplasms, Second Primary, +6 more
- Locations
-
- Centre François Baclesse Caen, France
- Centre Jean Perrin Clermont-Ferrand, France
- Centre Léon Bérard Lyon, France
- Institut Claudius Regaud Toulouse, France
NCT04647292
- Conditions
- Brain Diseases, Brain Ischemia, Cardiovascular Diseases, +19 more
- Locations
-
- Mater Misericordiae University Hospital Dublin, Ireland